Across the globe, Dexamethasone Sodium Phosphate prices followed an upward trajectory in the last two months and began to decrease in early December 2022. At the beginning of December 2022, Dexamethasone Sodium Phosphate prices anticipate a weak price trajectory in China and Germany. The shaky market attitude in Germany is expected to be validated by trade relations with China.

In China, Dexamethasone Sodium Phosphate prices for FOB Shanghai showed an increase of a total of 3.6% from October to November, even though the decline in Chinese economic activity. China's industrial activity, a vital driver of the nation's economic growth, continued to decline as further disruptions from COVID-19 cases were experienced. However, this resulted in a shortage of supply among domestic manufacturers. After that, Dexamethasone Sodium Phosphate prices moved down in early December, dragged by an increase in domestic inventory levels backed by a drop in overseas demand. The trading atmosphere in the end-user pharmaceutical market is general, and the overall manufacturing of the product is primarily based on demand. Besides, the worsened Covid-19 epidemic undermined transport, and the weak market fundamentals weighed down on Dexamethasone Sodium Phosphate prices.

Similarly, the fluctuating price trend showed that the German Dexamethasone Sodium Phosphate followed the market of the primary manufacturer and exporter of this API, i.e., China. The prices surged by a total of 5.5% in October-November. However, German traders had inadequate inventories of Dexamethasone Sodium Phosphate due to limited imports from China amid Covid-19 protocols. Meanwhile, producers from the end-user pharmaceutical industries looked through every possible tonne of stock in the market. However, the regional market's enormous demand-supply imbalance forced up the price of Dexamethasone Sodium Phosphate in Germany. Later, from the start of December, German supply chain disruption is starting to subside due to recent orders declines, resulting in a Dexamethasone Sodium Phosphate price decrement in the current month. Therefore, higher trade flows have resumed in Germany and the greater Eurozone due to some breathing room, but this does not indicate stable market fundamentals.

According to the ChemAnalyst analysis, towards the end of the year, the supply exceeding demand in the Dexamethasone Sodium Phosphate global market is hard to change, and it is expected that the market situation will be dull. However, end-user players mainly hold uncertain buying interests amid weak demand, triggering a bearish market outlook. The Dexamethasone Sodium Phosphate market dynamics might change in the first quarter of 2023. After the Christmas holidays, domestic markets will reopen, and end-user demand will likely increase. Moreover, the new productions will start as the inventory level may be low for the time being.